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Abstract
Purpose of Review The aim was to assess recent evidence that
diabetes, metabolic syndrome (MetS) and obesity impact the
progression of periodontitis.
Recent Findings Electronic searches using Embase,
Medline, and Web of Science were carried out for epide-
miological studies on humans, published between 2014
and 2016. A small number of prospective studies and
systematic reviews were identified that in general provide
further support for the hypothesis that diabetes, metabolic
syndrome and obesity can adversely affect the periodontal
condition.
Summary Confounding remains the most challenging is-
sue in the interpretation of the associations found between
diabetes, MetS, obesity and periodontal disease. Recent
research applying a Mendelian randomisation approach
concluded that the association between obesity and peri-
odontitis is confounded and questioned a role for obesity
in causation. Further studies are warranted to assess the
issue of causality.
Keywords Diabetes . Obesity .Metabolic syndrome .
Periodontitis . Mendelian randomisation
Introduction
The periodontitis-systemic disease relationship constitutes an
important part of clinical periodontal research. Research ac-
tivity has grown continuously since the late 1980s with about
one third of all recent periodontal studies now dealing with the
relationship between periodontal disease and systemic disease
[1•]. Further to this, a total of 57 different systemic disease
conditions are now being researched in relation to periodontal
diseases [2].
The periodontitis-systemic disease relationship is com-
monly described as being ‘two-way’ or ‘bi-directional’.
However, the design of many observational epidemiological
studies does not allow directionality to be firmly established
and so by default, any associations identified will be bi-
directional until data emerge that provide clarification.
Currently, we do not have a full understanding of the impor-
tance of the numerous associations reported and in particular
whether they play a part in causation. The conclusion of an
expert panel at the joint European Federation of
Periodontology/American Association of Periodontology
workshop on ‘Periodontitis and Systemic Diseases’ was that
‘reported associations do not imply causality and the estab-
lishment of causality would require new studies that fulfil the
Bradford Hill or equivalent criteria’ [3].
We have reviewed recent work published since 2014, fo-
cusing on prospective studies and systematic reviews where
these exist, to examine whether progress has been made. The
review is focused on systemic diseases or conditions that
could impact the development or progression of periodontitis.
Given the constraints of the large number of possible candi-
dates [2], we have limited the focus of this review to diabetes,
metabolic syndrome and obesity as they have been suggested
to have a causative role in periodontitis. Discussion of the
biological mechanisms through which these exemplars could
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increase the risk of periodontitis is beyond the scope of this
review. A further paper in this edition has reviewed studies of
periodontitis as a possible risk factor for systemic diseases.
Diabetes
Diabetes mellitus comprises a group of metabolic diseases in
which the characteristic phenotype is loss of control of glu-
cose homeostasis, resulting from defects in insulin secretion,
insulin action or both [4]. In 2015, there were an estimated 415
million people worldwide with diabetes and this is projected
to rise to 642 million by 2040 [5]. In 2015, more than 10% of
adults in 25 states of the USA had diabetes [6].
Baseline
It is widely accepted that there is a bi-directional association
between periodontitis and diabetes [7]. It is well documented
that periodontal disease is more prevalent and severe in those
with diabetes, but most studies supporting this observation
have been cross-sectional precluding the ability to firmly dem-
onstrate the direction of the association [8]. However, there
have been prospective studies and a good baseline for the
current review is a large study in the USA which suggested
diabetes control, but not aetiology (type 1 or type 2 diabetes),
was associated with accelerated periodontal attachment loss
progression [9]. This was reinforced by Taylor and colleagues
[10], who suggested it may be the level of metabolic control
and duration of diabetes that influence periodontal disease
risk, with a significant heterogeneity among diabetic
individuals.
Recent Studies
A recent prospective study investigated the influence of
glycaemic control on the progression of periodontitis during
periodontal maintenance therapy (PMT) [11]. Type 2 diabetes
mellitus (T2DM) control was monitored by HbA1c percent-
age over a 5-year period. Participants matched for sex and
smoking were divided into three groups: 23 with diabetes
and poor glycaemic control (PGC), 23 with diabetes and good
glycaemic control (GGC), and 46 controls with no diabetes
(NDC). Progression of periodontitis was defined as an in-
crease of interproximal clinical attachment loss of ≥3 mm in
at least two teeth. Progression of periodontitis was significant-
ly higher in the PGC compared to GGC andNDC participants.
Multiple logistic regressions showed that for progression of
periodontitis, a HbA1c ≥6.5% had an odds ratio (OR) of 2.9
(95% CI 1.43–9.81). A limitation was the small group sizes
which prevented stratification for the effect of smoking. There
was adjustment for smoking in the analysis; however, it was
not clear if there was an interaction between smoking and
glycaemic control. Despite this, and the restricted population
that the subjects were recruited from, the study did demon-
strate that poor glycaemic control significantly predicted risk
for the progression of periodontal destruction in those previ-
ously diagnosed with and treated for periodontitis.
A prospective study of 4033 Taiwanese subjects [12], aged
35–44, with no evidence of periodontitis, defined by a
Community Periodontal Index (CPI) score <3 [13], had their
fasting plasma glucose (FPG) measured at baseline. The num-
ber of newly diagnosed periodontitis cases (CPI score ≥ 3) at
re-examination after 5 years of follow-up was 1129 (28.0%)
normal FPG, 96 (32.3%) pre-diabetes, and 22 (38.6%) with
T2DM at baseline. Multivariable analysis using Cox’s propor-
tional hazard regression model showed an increased risk of
incident periodontitis for subjects with pre-diabetes (hazard
ratio (HR) = 1.25 (95% CI 1.00–1.57)) and T2DM
(HR = 1.95 (95% CI 1.22–3.13)) after adjustment for all po-
tential confounders. A novel finding of this study was the
significant effect of pre-diabetes on incident periodontitis
[12]. A limitation of the study was the use of the CPI score
to identify periodontitis [14]. Further weaknesses were lack of
information regarding the management of the hyperglycaemia
and its possible effects.
Based on the available evidence to date, it seems likely that
the level of metabolic control influences future periodontal
disease risk. However, further longitudinal studies are war-
ranted to assess what effect improved glycaemic control has
on the progression of periodontitis. The evidence examining
the influence of pre-diabetes as a condition that can potentially
adversely affect periodontal condition is inconclusive and also
requires further investigation as evidence can both be found
for [12] and against [15].
Metabolic Syndrome
Metabolic syndrome (MetS) relates to a cluster of disorders
including excess body fat around the waist and abdominal
area, increased blood pressure, elevated plasma glucose, ele-
vated serum triglycerides and reduced serum high-density li-
poprotein [16]. The most recent definition from the
International Diabetes Federation is the presence of central
obesity, defined as a waist circumference exceeding ethnic
specific guidelines, plus two from four of the other factors
[17]. It has been highlighted that 25% of the world’s adults
have MetS and as such, they have a fivefold greater risk of
developing T2DM [17].
Baseline
The baseline for MetS and periodontitis is the systematic re-
view and meta-analysis completed by Nibali and colleagues
which used data from 19 cross-sectional and only one
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longitudinal study [18]. MetS was associated with the pres-
ence of periodontitis with an OR of 1.71 (95% CI 1.42–2.03);
however, there was evidence of heterogeneity.
Recent Studies
A further systematic review reported a significant number of
studies demonstrating a positive association between MetS
and periodontitis [19]. However, the authors did highlight that
virtually, all evidence for the association was based on cross-
sectional studies and throughout, there was considerable var-
iation both in the measures of periodontal disease and the
definitions of MetS [19].
The impact of MetS on the progression of periodontal dis-
ease was investigated in 125 older adults from Japan [20].
Development of periodontal disease was equated with ≥2
teeth demonstrating a longitudinal loss of proximal periodon-
tal attachment of ≥3 mm over 3 years of follow-up. At base-
line, 27 (21.6%) of the participants were determined to have
MetS. Subjects with baseline MetS were 2.6 (95% CI 1.17–
5.67) times more likely to develop periodontitis during the
observation period after adjustment for known confounders.
Limitations of the study included the small sample size, the
length of follow-up and also the lack of detail with regard to
the management of MetS and whether changes in components
of this may have had an impact in terms of periodontal disease
development.
A further prospective study investigated 760 men in the
Department of Veterans Affairs Dental Longitudinal Study
and Normative Ageing Study who were followed for up to
33 years in the USA [21•]. The men’s oral health, weight,
medical health and lifestyle were monitored approximately
every 3 years, meaning that instead of just baseline values,
time-dependent repeated measurements of MetS components
were available. Periodontal outcome events on each tooth
were defined as progression to predefined threshold levels of
probing pocket depth (≥5 mm), clinical attachment loss
(≥5 mm) and evidence of radiographic alveolar bone loss
(≥40% of the distance from the cementoenamel junction to
the root apex). The statistical models, used to estimate the
effect of MetS for periodontitis events, took account of both
clustering of teeth within individuals and the time-dependent
status of metabolic syndrome. MetS increased the hazard ra-
tios for pocket depth ≥5 mm (HR = 1.37 (95%CI 1.14–1.65)),
clinical attachment loss ≥5 mm (HR = 1.19 (95% CI 1.00–
1.41)) and alveolar bone loss ≥40% (HR = 1.25 (95% CI
1.00–1.56)). The number of positive metabolic syndrome fac-
tors was also associated with each of these outcomes. The
prospective design and extended follow-up period provides
certain robustness to the observed association that MetS pre-
dicts worsening periodontal disease in men. A limitation is the
study population, who were predominantly non-Hispanic
white males in a small area of the USA, and there is therefore
limited external validity.
Obesity
Obesity has been defined as a systemic disease characterized
by excessive body fat accumulation that can lead to adverse
impacts on health conditions [22]. The World Health
Organization reported about 13% of the world’s adult popula-
tion (11% of men and 15% of women) were obese in 2014
[23]. The worldwide prevalence of obesity more than doubled
between 1980 and 2014 [23]. This increase in global preva-
lence has been more notable in certain developed countries,
such as the UK, where obesity prevalence has increased from
15% in 1993 to 26% in 2014 [24]. In the USA, adult obesity
rates now exceed 35% in four states, 30% in 25 states and are
above 20% in all states [25].
Baseline
Systematic reviews with meta-analyses have identified mod-
est positive associations between obesity and periodontitis
with respective OR = 1.35 (95% CI 1.23–1.47) [26], and
OR = 1.81 (95%CI 1.42–2.30) [27], being reported. A long-
term prospective study in the USA of non-Hispanic white men
with robust criteria for periodontitis found that obesity and
central adiposity were associated with an increased risk of
the progression of periodontal disease [28]. A large prospec-
tive study of 36,910 healthcare professionals also reported a
significant association between obesity and self-reported
periodontitis [29].
Recent Studies
A recent systematic review only considered prospective lon-
gitudinal studies assessing the association between weight
gain and the incidence of periodontitis [30]. Five studies ful-
filled the inclusion criteria and were appropriate for meta-anal-
ysis. The component studies were conducted in high-income
countries including one study in Finland, two in Japan and
two in the USA. The combined collective sample size was
42,198 individuals. The meta-analysis showed that subjects
who became overweight had an increased relative risk of
1.13 (95% CI 1.06–1.20) of developing periodontitis com-
pared with counterparts who stayed normal weight. For those
who became obese, the relative risk was higher at 1.33 (95%
CI 1.21–1.47). The results do provide a clear positive associ-
ation between weight gain and new cases of periodontitis.
However, the authors did point out that this conclusion was
based on limited evidence and highlighted the need for further
longitudinal prospective studies in low- and middle-income
countries.
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One prospective study investigated the effect of obesity on
periodontal attachment loss (PAL) progression in an urban
population from south Brazil [31]. Progression of periodonti-
tis was defined as proximal PAL of ≥3 mm in ≥4 teeth over
5 years of follow-up in 582 (333 males/249 females) partici-
pants. Females who were obese at baseline were at statistically
significant higher risk of periodontitis progression than those
who were normal weight with a relative risk of 1.64 (95% CI
1.11–2.43). No association was observed for males with a
relative risk of 1.13 (95% CI 0.75–1.69). This suggests obe-
sity in this population from South America was a risk factor
for PAL progression in females but not in males. A major
limitation was the high dropout rate. At baseline, 1568 sub-
jects were screened but only 755 re-attended at 5 years, of
which 582 met the inclusion criteria for analysis in this study.
A further limitation was the lack of diabetes assessments. This
is particularly important in obesity studies as it is well
established that diabetes is associated with both obesity and
periodontitis. Therefore, diabetes could have been a con-
founder of the association reported between obesity
and periodontitis [32].
Association or Causation
What overall interpretation can be placed on the studies to
date? Many observational studies have reported associations
which could reflect causal involvement of an exposure in the
aetiology of a disease or condition that subsequently could not
be confirmed by large-scale prospective randomized con-
trolled trials (RCTs) [33•]. One classical example is the find-
ing from longitudinal studies that hormone replacement ther-
apy (HRT) led to a reduction in the risk for coronary heart
disease (CHD). The obvious conclusion was that HRT had a
protective effect; however, when prospective RCTs were com-
pleted, it became evident that HRT was actually responsible
for an increased risk of CHD [34•]. This was explained by the
‘healthy-user effect’ whereby women who took HRT tended
to be better educated, more aware of their health, likely to take
other preventive advice, to be less likely to smoke, etc. These
factors therefore confounded the association, and this is likely
to have affected many observational studies resulting in the
identification of spurious associations [35]. A major weakness
of observational studies is that there is no protection against
confounding. Most studies use statistical techniques to adjust
for obvious confounders; however, there may be residual con-
founding reflecting the difficulty in controlling for all dimen-
sions of relevant factors [33•]. This is a particular problem for
studies investigating exposures such as obesity and diseases
such as periodontitis which can be affected by factors which
are difficult to measure such as behaviour in social networks
[36], socioeconomic status and health service utilization [33•].
In addition, there is no protection against unknown or unrec-
ognized confounders.
If we accept that confounding is a challenging issue, how
can we test whether a disease or condition such as obesity is a
causative factor for periodontitis? One way to control for con-
founding is to apply a randomized design. RCTs are used to
test the effectiveness of interventions and are the gold standard
for validating a particular method of treatment. From ethical
and practical viewpoints, it is difficult to envisage an RCT
with a test group who are provided with a mechanism to be-
come obese and a control group who maintain normal weight.
There are few conclusions on the natural history of disease
that are supported by prospective RCTs [37]. The best that
might be achieved are prospective cohort studies looking at
incident cases; however, these are also liable to bias and
confounding.
Mendelian randomization (MR), a method which exploits
the random assignment of genes from parents to their children
at meiosis, could provide a solution [33•]. In MR, a genetic
variant associated with a phenotype is used as an instrumental
variable (IV) to evaluate the causal relationship between that
phenotype and the outcome of interest. The fundamental con-
sideration is that the IV is regarded as independent of con-
founders [38•]. Therefore, if we can identify a gene variant
which is closely linked to a putative risk factor, then we may
be able to use MR to assess whether it is a true causal
aetiological factor. In this context, variants in a number of
genes have been shown to be associated with obesity [39,
40]. Subsequently, MR has been used to show that greater
adiposity leads to higher CRP levels with no evidence of
any reverse pathway [41], and that higher body mass index
(BMI) has a causal relationship with cardiometabolic traits
including heart failure, metabolic syndrome and type 2
diabetes [38•].
The Gene Lifestyle Interactions and Dental Endpoint
(GLIDE) consortium applied MR to test whether there was a
causal relationship between obesity and periodontitis [42•].
GLIDE had access to BMI, periodontal status and relevant
genotype data from 13 studies of up to 68,761 individuals.
Genotypes at FTO (rs1121980), MC4R (rs17782313) and
TMEM18 (rs6548238) which represent the largest known ef-
fect sizes for BMI in European populations were used to pro-
vide a genetic risk score (GRS). Definitions of periodontitis
were those applied in each of the participating cohorts. Higher
BMI was significantly associated to periodontitis after adjust-
ment for known confounders in subjects (n = 29,459) who had
been clinically assessed for periodontitis (odds ratio 1.13
(95% CI 1.10–1.17). In obese compared with normal weight
participants, the relationship was stronger OR = 1.33 (95% CI
1.18–1.50). The genotypes used were associated with BMI
with a statistically significant trend in mean BMI per GRS
unit. However, when BMI-associated genotypes were studied
in relation to periodontitis, there were no significant
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associations in those with clinically assessed periodontitis
(10,972 cases, 9681 controls) with the pooled OR = 1.00
(95%CI 0.97–1.03) per risk allele. The authors concluded that
their MR analysis did not support a role for total adiposity as a
causal risk factor for periodontitis [42•].
We completed a further MR analysis on 1271 dentate men
in Northern Ireland who were participating in the PRIME
study (for details of participants, see [43]). The adiposity-
associated variant rs17782313 in melanocortin-4 receptor
(MC4R) was used as an instrumental variable for waist cir-
cumference (WC) in an MR design. There was a significant
association between variants in rs17782313 and WC
(p = 0.01). Increased abdominal adiposity was significantly
associated (p = 0.007) with increased periodontal attachment
loss (PAL) which was used to measure periodontitis.
However, when the instrumental variable was applied to in-
vestigate the effect of WC on PAL, the association was not
significant. This further independent study using an MR ap-
proach did not support a causal relationship between abdom-
inal adiposity and periodontitis. The results of these recent
MR studies suggest that the epidemiological association be-
tween obesity and periodontitis may be confounded. The pos-
sibility of reverse causality, i.e. in the direction from periodon-
titis to obesity cannot be excluded by the MR studies de-
scribed. Further speculation on periodontitis as a possible
causative factor for obesity is beyond the scope of this review.
Conclusion
Evidence from many observational studies, including an in-
creasing number of prospective studies, supports associations
between the conditions described (diabetes, MetS, obesity)
with periodontitis. There is a need for balanced professional
judgement of how meaningful these associations are. In this
context, one recurrent problem is the substantial variations in
the definitions used to identify periodontitis with few studies
that meet stringent criteria for periodontitis [32]. Confounding
remains the most challenging issue in the interpretation of the
associations found between various health states such as those
discussed in this review (diabetes, MetS, obesity) and peri-
odontal disease. However, where it has been possible to inter-
rogate one possible association, in the absence of confound-
ing, recent studies using an MR approach do not provide ev-
idence that supports obesity as a causative factor for periodon-
titis in contradiction to the outcomes of observational studies
[42•]. One limitation to this method is that it can only be used
where there are suitable functional polymorphisms, or
markers linked to functional polymorphisms, that are relevant
to the exposure of interest. However, it is possible that these
may be identified; for example, there is increasing evidence
that genetic variants are associated with T2DM [44]. Until
further progress is made, we should accept that the
associations reported may be important and periodontal diag-
nostic procedures should be routinely carried out in patients
who present with diabetes, MetS and obesity.
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